Jemincare

This study tested a new drug, JYB1904, in 69 adults with allergic asthma. Participants received either JYB1904 every 8 weeks or the standard drug omalizumab every 2 to 4 weeks for 24 weeks. The goal was to see how the drug behaves in the body, how safe it is, and how well it cont…

This study tested a drug called sonidegib in 160 Chinese adults with a type of advanced skin cancer (basal cell carcinoma) that could not be treated with surgery or radiation. The drug is taken as a capsule and works by blocking signals that help cancer grow. The main goal was to…